West Pharmaceutical steady on Friday, S&P 500 peer group shows mixed moves
27.06.2026 - 14:34:35 | ad-hoc-news.deBy Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-27, 14:34.
West Pharmaceutical Services (US9523901012) opens the last trading day of the week with a stable share profile on the NYSE. The stock closed Thursday around 351 dollars per share, broadly in line with recent weeks, according to price data on MarketBeatWest Pharmaceutical Services price overview on MarketBeat.
Where West Pharmaceutical stands among peers
West Pharmaceutical Services shares trade in the large-cap U.S. health-care equipment segment alongside companies such as Becton Dickinson and Medtronic, both members of the S&P 500 health-care complexS&P Dow Jones Indices sector breakdown. In recent sessions, the West Pharmaceutical stock price has held near the mid-300 dollar region, while broader sector performance has been mixed, with some medical device peers recording modest single-digit moves week to dateReuters U.S. market and sector wrap.
The company’s market capitalization sits in the multi-billion dollar range, reflecting its role as a key supplier to the pharmaceutical and biotech industriesYahoo Finance profile for West Pharmaceutical Services. Compared with diversified conglomerates such as Thermo Fisher or Danaher, West Pharmaceutical is more narrowly focused on drug-packaging and delivery systems, which gives its earnings profile a distinct exposure to volume trends in injectable medicinesWest Pharmaceutical corporate overview.
Sector performance at the end of the week
On Friday, U.S. health-care stocks in the S&P 500 show a mixed picture, with defensive names broadly steady while select biotech and medical equipment companies edge higher or lower by low-single-digit percentages, per sector data compiled by ReutersReuters global stocks and sector performance. Within this backdrop, West Pharmaceutical shares remain close to recent closing levels, reflecting a muted short-term reaction in the absence of fresh company-specific news catalysts seen in regulatory filings or major press releasesSEC EDGAR search for West Pharmaceutical Services.
Investors in the sector are watching near-term macro drivers such as U.S. interest-rate expectations and health-care policy headlines, which influence valuation multiples across the defensive growth names in the indexFinancial Times commentary on health-care equities. Against this broader context, the West Pharmaceutical stock trades as a specialized supplier rather than a diversified pharmaceutical manufacturer, which positions it differently from peers like Pfizer or Johnson & Johnson in sector comparisonsMorningstar sector classification for West Pharmaceutical Services.
Further news and analysis on West Pharmaceutical Services
More background, price data and corporate disclosures on West Pharmaceutical Services can be found in the dedicated topic section and on the company’s Investor Relations page.
The product platform behind the stock
West Pharmaceutical Services generates most of its revenue from specialized packaging and delivery systems for injectable drugs, including elastomeric components, prefillable syringe systems and vial containment solutionsWest Pharmaceutical products overview. One representative product line is its high-value NovaPure components, which are designed to help reduce particulate contamination and meet stringent regulatory requirements for sensitive biologic therapiesWest Pharmaceutical NovaPure components information.
Current trading snapshot for the shares
West Pharmaceutical Services shares (US9523901012) last traded on the NYSE at approximately 351 dollars per share, based on the closing price from 2026-06-26, 15:59 Eastern Time, with the extended session showing only marginal changes in after-hours activityMarketBeat closing and extended-hours data for West Pharmaceutical Services.
West Pharmaceutical Services at a glance
- Company: West Pharmaceutical Services, Inc.
- ISIN: US9523901012
- WKN: 877507
- Ticker: WST
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 351.07 USD
- Market cap: roughly 25 billion USD (as of 2026-06-26)
- Sector / industry: Health Care - Health-Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer or solicitation to buy or sell any financial instrument. Historical data and peer comparisons are based on sources deemed reliable but cannot be guaranteed. Investors should conduct their own research or consult a licensed financial advisor before making investment decisions.
